THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The present predicament has exposed some structural weaknesses from the EU’s medicines supply chain in addition to a superior dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She suggested that offer chain problems be tackled within an EU pharmaceutical approach anticipated for being introduced by